Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Long-term Study of S-8117 (Oxycodone) in Chronic Pain
jRCT2080222035Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oxycodone in chronic pain, osteoarthritis (OA), diabetic neuropathy and 1 more, sponsored by Shionogi & Co., Ltd.
02
Drugs
oxycodone
03
Conditions
chronic painosteoarthritis (OA)diabetic neuropathypostherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2080222035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222035.